The caspase-1-specific inhibitor YVAD-cmk significantly abolished the E2-induced inhibition of growth of HCC cells effect, suggesting that E2 induced the death of HCC cells by promoting NLRP3 inflammasome-caspase-1 dependent pyroptosis. The gene discussed is CASP1; the disease is hepatocellular carcinoma.